Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy (NCT05180773)
Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)
🩺 Plain-English Summary (8th-Grade Level)
The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on myocardial recovery and clinical outcomes. Given that bromocriptine prevents breastfeeding, an additional 50 women with peripartum cardiomyopathy excluded from the trial due to a desire to continue breastfeeding but meeting all other entry criteria will be followed in an observational cohort.
Who can join: Review the eligibility criteria below.
Location: University of Alabama Birmingham — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (64 Sites)
Showing the first 25 of 64 sites.
- University of Alabama Birmingham — Birmingham, Alabama
- University of Arizona Sarver Heart Center — Tucson, Arizona
- University of California San Diego — La Jolla, California
- Keck School of Medicine of USC — Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California
- University of California Irvine Health — Orange, California
- Stanford University — Stanford, California
- University of Colorado Anschutz Medical Campus — Aurora, Colorado
- Hartford Hospital — Hartford, Connecticut
- Yale University — New Haven, Connecticut
- University of Florida — Gainesville, Florida
- Mayo Clinic, Florida — Jacksonville, Florida
- University of South Florida — Tampa, Florida
- Emory University — Atlanta, Georgia
- Northwestern University — Chicago, Illinois
- University of Illinois Health Heart Center — Chicago, Illinois
- Indiana University/Indiana University Health — Indianapolis, Indiana
- Ascension St. Vincent Heart Center — Indianapolis, Indiana
- University of Iowa Hospitals and Clinic — Iowa City, Iowa
- University of Kentucky, Gill Heart & Vascular Institute — Lexington, Kentucky
- Louisiana State University — Shreveport, Louisiana
- University of Maryland Medical Center, Baltimore — Baltimore, Maryland
- Johns Hopkins University — Baltimore, Maryland
- Massachusetts General Hospital — Boston, Massachusetts
- Brigham and Women's Hospital — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: (412) 802-3131
Email: mcnamaradm@upmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Peripartum Cardiomyopathy, Postpartum clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.